Millendo Therapeutics
Latest round
- Series B
Last raised
- Dec 2015
Total raised
- $56M
Investors
- 11
About Millendo Therapeutics
Millendo Therapeutics, Inc. is a biotechnology firm focused on developing innovative oncology therapeutics.Millendo Therapeutics, Inc. specializes in biopharmaceutical development, particularly for oncology therapies. Founded in 2012, the company is headquartered in Ann Arbor, Michigan, US. Gary Hammer, a notable figure in the biotech sector, is one of the founders. The firm has undergone a significant transformation, including a reverse merger with OvaScience, Inc. in August 2018, which has enhanced its operational capabilities.Millendo Therapeutics focuses on developing first-in-class oral drug therapeutics aimed at treating various forms of cancer. Their flagship product, Amezalpat (TPST-1120), is currently undergoing pivotal trials for first-line hepatocellular carcinoma (HCC) in China, targeting specific cancer pathways to enhance treatment efficacy and reduce adverse effects. Collaborations with pharmaceutical companies are intended to facilitate joint development of their innovative treatments, potentially leading to shared revenues post-commercialization.Looking ahead, Millendo Therapeutics plans to expand its product lineup and geographical presence. The focus includes advancing Amezalpat towards regulatory approval and exploring additional oncology therapies. Additionally, Millendo aims to solidify its market position in China and other targeted regions by the next few years, enhancing its ability to deliver innovative cancer therapies.
Who invested in Millendo Therapeutics
11 investors across 4 rounds
See all investors in Millendo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Millendo Therapeutics
Who invested in Millendo Therapeutics?
Millendo Therapeutics has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Millendo Therapeutics raised?
Millendo Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Millendo Therapeutics last raise money?
Millendo Therapeutics's most recent round on record is a Series B, in Dec 2015.
What does Millendo Therapeutics do?
Millendo Therapeutics is a pharmaceuticals company.
Where is Millendo Therapeutics headquartered?
Millendo Therapeutics is headquartered in Ann Arbor, US.
Which VCs invest in companies like Millendo Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Millendo Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Millendo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.